Chief Executive Officer, Atomo Diagnostics
"The two kicked off in parallel, so to me they are quite interconnected. I felt I needed to become a more rounded executive to grow a global business and the Global EMBA offered a very digestible format. I found my business plan also got adjusted and improved based on learning and experiences generated over the 18-month course."
John Kelly's company Atomo Diagnostics was recently awarded a grant from Commercialisation Australia. His bright idea was to bring to market the world's first fully integrated rapid blood test device designed for both clinical and home-based environments. The innovative easy-to-use MicroRapid device can be used to test for cardiac and cancer markers, common infectious diseases, as well as self-screening for conditions such as celiac, allergies, thyroid imbalances and anemia. Kelly had a track record of developing successful products with next-generation usability and embarked on setting up Atomo Diagnostics at the same time he commenced his Global Executive MBA.